Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 62/958,892, filed Jan 9, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,721,847 | Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors In force · High confidence UsedRemaining | Disc Medicine, Inc. | In force | High confidence | ||
| US 11,813,257 | Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors In force · High confidence | Disc Medicine, Inc. | In force | High confidence | ||
| Application 18/941,469 | Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors Abandoned Abandoned Oct 21, 2026 | Disc Medicine, Inc. | Abandoned | Abandoned Oct 21, 2026 | ||
| Application 18/280,774 | Compositions and Methods for Treating Anemia Associated with a Ribosomal Disorder Pending Not granted | Disc Medicine, Inc. | Pending | Not granted | ||
| Application 18/280,837 | Compositions and Methods for Treating Polycythemia Pending Not granted | Disc Medicine, Inc. | Pending | Not granted | ||
| Application 18/290,403 | Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors Pending Not granted | Disc Medicine, Inc. | Pending | Not granted | ||
| Application 18/562,510 | Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with a Solid Form of Bitopertin Pending Not granted | Disc Medicine, Inc. | Pending | Not granted | ||
| Application 18/866,586 | Compositions and Methods for Treating Hepatic Porphyrias with Glycine Transport Inhibitors Pending Not granted | Disc Medicine, Inc. | Pending | Not granted | ||
| Application 18/923,904 | Compositions and Methods for Treating Polycythemia Pending Not granted | Disc Medicine, Inc. | Pending | Not granted | ||
| Application 19/077,940 | Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors Pending Not granted | Disc Medicine, Inc. | Pending | Not granted | ||
| 4 more records in this group · Pro | ||||||
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14.
2 of these are in force and held by Disc Medicine, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.